The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of regorafenib plus ICIs as second-line treatment in advanced HCC post-frontline treatment failure: A real-world study from a single center.
 
Lingzhan Meng
No Relationships to Disclose
 
Hu Li
No Relationships to Disclose
 
Peng Yu
No Relationships to Disclose
 
Li Cao
No Relationships to Disclose
 
Zizheng Wang
No Relationships to Disclose
 
Jin Yan
No Relationships to Disclose
 
Yanling Shao
No Relationships to Disclose
 
Bin Shi
No Relationships to Disclose
 
Zhenyu Zhu
No Relationships to Disclose